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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S239Purpose: Innate immune response components such as Toll-like receptors
(TLRs), NLRP3 inﬂammasome and the intracellular signaling molecule
MyD88 are all expressed by synovial membrane and chondrocytes.
Previous studies have shown that TLR and NLRP3 inﬂammasome act in
concert to increase IL-1b secretion by activated synovial macrophages and
that IL-1b could be an important mediator involved in the pathogenesis of
osteoarthritis (OA). The aim of our study was to evaluate the role of various
TLRs, NLRP3 and the signaling molecule MyD88 in a murine model of OA
induced by knee menisectomy (MNX, surgical removal of the medial
meniscus).
Methods: Knees from 8-10 weeks old C57Bl6 wild type female (n¼7),
knock-out TLR-1 (n¼5), -2 (n¼7), -4 (n¼8) -6 (n¼5), NLRP3 (n¼9) or
MyD88 (n¼7) were menisectomized, using the sham-operated contralat-
eral knee as a control. 8 weeks later mice were sacriﬁced and knee carti-
lage destruction evaluated by histology using the OARSI scoringmethod. In
addition, apoptotic chondrocytes were quantiﬁed in MyD88- and NLRP3-
deﬁcient knees. Finally, synovial inﬂammation was also scored.
Results: Operated knees exhibit OA symptoms at 8 weeks post-surgery
compared to sham-operated knees as evidenced by both femoral and tibial
cartilage degradation (increased OARSI score parameters, increased
chondrocyte apoptosis) and by synovial inﬂammation. In menisectomized
TLR-1, -2, -4, and -6 deﬁcient mice, severity and extent of cartilage lesions
and synovial inﬂammation were similar to that in MNX wild-type mice.
Using the same approach, we found that the phenotype of NLRP3-deﬁcient
mice was similar to that of wild-type mice. Accordingly, we did not ﬁnd
a signiﬁcant effect of MyD88 deletion, as cartilage erosion and synovial
inﬂammation were similar in MNX knock-out and wild-type mice.
Conclusions: Knee MNX recapitulates features of OA, i.e, cartilage
destruction and synovial inﬂammation. Deﬁciency of TLRs, NLRP3
inﬂammasome and their signaling molecule MyD88 did not impact on the
severity of experimental OA. Our results suggest that NLRP3 inﬂamma-
some is either not involved in IL-1b activation or that IL-1b is not a key
mediator in this murine OA model. This latter hypothesis is strengthened
by the lack of efﬁciency of IL-1b antagonists in the treatment of OA.
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CELECOXIB DECREASES THE PRODUCTION OF CYTOKINES BY
OSTEOARTHRITIC CARTILAGE AND SYNOVIUM WITHOUT AFFECTING
CARTILAGE MATRIX DEGRADATION.
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Purpose: Recently, we reported a coculture model with osteoarthritic
cartilage and synovial tissue that is more representative for osteoarthritis
(OA) and useful to study mechanisms of action of OA therapies. Celecoxib,
a COX-2 inhibitor, is frequently used for the treatment of osteoarthritis.
However, its effect on cartilage metabolism has been the subject of much
debate. Moreover, it is unclear how celecoxib affects the levels of soluble
mediators in the joint. In the current study we investigate the effect of
celecoxib on cartilage matrix turnover and the secretion of soluble medi-
ators by cartilage and synovium in a coculture of OA cartilage and synovial
tissue.
Methods: OA cartilage and OA synovium explants were cultured alone or
in coculture for 21 days with the addition of celecoxib at 0.1, 1.0 and 10 mM.
To study cartilage matrix turnover glycosaminoglycan (GAG) content,
production and release were determined. ELISAs for IL-1a, IL-1ß, IL-4, IL-6,
IL-8, IL-10, IL-13, OSM, MCP1, NGF, leptin, adiponectin and PGE2 were
performed on conditioned medium of day 4. For statistical analysis,
univariate analysis of variance was performed, with a randomized block
design to correct for inter-donor variability. P values < 0.05 were consid-
ered signiﬁcantly different.
Results: Both osteoarthritic cartilage and synovial tissue produced PGE2
and celecoxib inhibited the production in a dose dependent manner (P <
0.05; Fig. 1a). Celecoxib, irrespective of the concentration used, did not
show an effect on GAG content, release and production in the coculture
(Fig. 1b). Celecoxib at a concentration of 10 mMdecreased the production of
IL-1a, IL-1ß, IL-6, IL-10, OSM and NGF (P < 0.05). No effect was seen on
leptin, adiponectin, IL-8 and MCP1. IL-13 and IL-4 were not detected
(Fig. 1c).Figure 1. Effect of 10 mM celecoxib on PGE2 production, GAG content, production and
release and soluble mediators in coculture of OA cartilage explants and synovial tissue.
A: Celecoxib decreased PGE2 production (1 representative donor; * P < 0.05). B: No
effect on GAG content, production and release (average +/- sd of 3 OA donors; n¼4
donor/condition). C: Production of IL-1a, IL-1b, IL-6, IL-10, OSM and NGF is decreased
by 10 uM celecoxib (average +/- sd of 3 donors; n¼4 donor/condition; * P < 0.05).
Conclusion: This study shows that celecoxib decreased the production of
multiple soluble mediators associated with inﬂammation and pain in OA.
Although the production of multiple pro-inﬂammatory cytokines and
PGE2 was decreased, no effect on cartilage matrix turnover was seen. The
decreased production of mediators associated with pain in OA, such as
NGF, IL-6 and PGE2 is in line with the effect on pain observed in patients
treated with celecoxib.
471
PRO-RESOLVING LIPID MEDIATORS ARE PRESENT IN THE JOINTS OF
OSTEOARTHRITIS PATIENTS
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Purpose: Pro-resolving lipid mediators (LM), such as resolvins, protectins
and maresins, are powerful molecules that have a critical role in limiting
inﬂammation and promoting tissue regeneration. Biochemically they are
derived from the enzymatic oxygenation of poly-unsaturated fatty acids by
lipoxygenases (LOX). Some LOX involved in the generation of pro-resolving
LM have been suggested to play a role in the pathophysiology of osteoar-
thritis (OA) in humans. However, it is currently unclear whether pro-
resolving pathways are activated in the osteoarthritic joint, as the presence
of pro-resolving LM or their precursors was not yet investigated. Therefore,
we aimed at investigating the presence and abundance of pro-resolving
LM and their precursors in synovial ﬂuid (SF) of OA patients compared to
Rheumatoid Arthritis (RA) patients.
Methods: SF samples from OA (n ¼ 8) and RA (n ¼ 9) patients visiting the
outpatient clinic of the department of Rheumatology were collected. A
targeted LC-MS(MS) lipidomics platform based on a QTrap mass spec-
trometer for the highly sensitive determination of several lipid mediators
was used.
Results: The presence of LM could be proven in 4 of the OA and 5 of the RA
patient samples. The pro-resolving LM resolvin D5 and maresin 1 were
readily detectable and were accompanied by the presence of pro-inﬂam-
matory mediators such as leukotriene B4 and anti-inﬂammatory LM, such
as lipoxin A4 and B4. Notably, the pro-inﬂammatory prostaglandins E2 and
D2 could be detected in only 1 OA sample, while they were present in all 5
RA samples. Hydroxy derivatives of polyunsaturated fatty acids (HETE,
HEPE and HDHA) which are precursors and biomarkers for LM were
additionally detected in both patient groups.
Conclusions: This study indicates that a previously unrecognized pathway
is likely activated in the knee joint of OA patients, as evidentiated by the
presence of pro-resolving LM and their precursors in SF of these patients.
